Walvax Biotechnology (300142.SZ) plans to invest 450 million yuan to establish the Yunnan Chuang Wo Biological Industry Investment Fund.

Walvax Biotechnology (300142.SZ) announced that on February 10, 2026, the company held the second meeting of the sixth board of directors and approved the proposal of "Participating in Joint Investment with Professional Investment Institutions and Signing the Yunnan Chuangwo Biological Industry Investment Fund Limited Partnership Agreement." The board of directors agreed that the company would cooperate with Guotou Chuangyi Industrial Fund Management Co., Ltd. (hereinafter referred to as "Guotou Chuangyi"), Yuxi State-owned Capital Operation Co., Ltd., and Central Enterprises Rural Industry Investment Fund Co., Ltd. to jointly establish the Yunnan Chuangwo Biological Industry Investment Fund, and sign the "Yunnan Chuangwo Biological Industry Investment Fund Limited Partnership Agreement" (hereinafter referred to as the "Partnership Agreement"), with a target fund size of 1 billion yuan, of which the company will contribute 450 million yuan in capital as a limited partner. According to the agreement, the core investment direction of Yunnan Chuangwo Biological Industry Investment Fund focuses on synthetic biology, bio-manufacturing, and biotechnology-related industries. This cooperation is in line with the national biotechnology development plan and is beneficial for the company to create multiple opportunities to obtain industry dividends. The company can leverage Guotou Chuangyi's rich industry resources to rapidly expand its business channels, reach more high-quality market opportunities and partners, gain more initiative in fund project negotiations, and directly participate in fund operations. This allows the company to have closer contact with high-quality targets in related fields, obtain scarce opportunities for direct cooperation with target companies, and lay a foundation for future industrial synergy and strategic mergers and acquisitions.